{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T12:22:47Z","timestamp":1761567767096,"version":"build-2065373602"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pet.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["PET Clinics"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.cpet.2018.08.006","type":"journal-article","created":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T19:38:59Z","timestamp":1540409939000},"page":"103-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Skeletal Metastasis Evaluation"],"prefix":"10.1016","volume":"14","author":[{"given":"Stephen M.","family":"Broski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason R.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse T.","family":"Kendi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rathan M.","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cpet.2018.08.006_bib1","first-page":"7","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.cpet.2018.08.006_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.aju.2016.06.004","article-title":"Oligometastatic prostate cancer: metastases-directed therapy?","volume":"14","author":"Van Poppel","year":"2016","journal-title":"Arab J Urol"},{"issue":"8","key":"10.1016\/j.cpet.2018.08.006_bib3","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cpet.2018.08.006_bib4","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/bonekey.2015.122","article-title":"Mechanisms of osteolytic and osteoblastic skeletal lesions","volume":"4","author":"David Roodman","year":"2015","journal-title":"Bonekey Rep"},{"issue":"4","key":"10.1016\/j.cpet.2018.08.006_bib5","first-page":"381","article-title":"Which metabolic imaging, besides bone scan with 99mTc-phosphonates, for detecting and evaluating bone metastases in prostatic cancer patients? An open discussion","volume":"59","author":"Bombardieri","year":"2015","journal-title":"Q\u00a0J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.cpet.2018.08.006_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0001-2998(72)80005-9","article-title":"18 F-fluoride for bone imaging","volume":"2","author":"Blau","year":"1972","journal-title":"Semin Nucl Med"},{"issue":"5","key":"10.1016\/j.cpet.2018.08.006_bib7","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1148\/rg.345130061","article-title":"Newer PET application with an old tracer: role of 18F-NaF skeletal PET\/CT in oncologic practice","volume":"34","author":"Bastawrous","year":"2014","journal-title":"Radiographics"},{"issue":"7","key":"10.1016\/j.cpet.2018.08.006_bib8","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.2967\/jnumed.113.135475","article-title":"Impact of (18)F-fluoride PET on intended management of patients with cancers other than prostate cancer: results from the national ONCOLOGIC PET registry","volume":"55","author":"Hillner","year":"2014","journal-title":"J\u00a0Nucl Med"},{"issue":"3","key":"10.1016\/j.cpet.2018.08.006_bib9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2967\/jnumed.117.205047","article-title":"Intended versus inferred treatment after 18F-fluoride PET performed for evaluation of osseous metastatic disease in the national oncologic PET registry","volume":"59","author":"Hillner","year":"2018","journal-title":"J\u00a0Nucl Med"},{"issue":"3","key":"10.1016\/j.cpet.2018.08.006_bib10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2967\/jnumed.117.205120","article-title":"Hospice admission and survival after 18F-fluoride PET performed for evaluation of osseous metastatic disease in the national oncologic PET registry","volume":"59","author":"Gareen","year":"2018","journal-title":"J\u00a0Nucl Med"},{"issue":"2","key":"10.1016\/j.cpet.2018.08.006_bib11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/RLU.0000000000000592","article-title":"Performance of 18F-fluoride PET or PET\/CT for the detection of bone metastases: a meta-analysis","volume":"40","author":"Shen","year":"2015","journal-title":"Clin Nucl Med"},{"issue":"2","key":"10.1016\/j.cpet.2018.08.006_bib12","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s11307-011-0486-2","article-title":"Prospective evaluation of (99m)Tc MDP scintigraphy, (18)F NaF PET\/CT, and (18)F FDG PET\/CT for detection of skeletal metastases","volume":"14","author":"Iagaru","year":"2012","journal-title":"Mol Imaging Biol"},{"issue":"3","key":"10.1016\/j.cpet.2018.08.006_bib13","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1097\/RLU.0000000000000560","article-title":"Detection of osseous metastasis by 18F-NaF\/18F-FDG PET\/CT versus CT alone","volume":"40","author":"Sampath","year":"2015","journal-title":"Clin Nucl Med"},{"issue":"12","key":"10.1016\/j.cpet.2018.08.006_bib14","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.2967\/jnumed.115.162610","article-title":"Prospective comparison of 99mTc-MDP scintigraphy, combined 18F-NaF and 18F-FDG PET\/CT, and whole-body MRI in patients with breast and prostate cancer","volume":"56","author":"Minamimoto","year":"2015","journal-title":"J\u00a0Nucl Med"},{"issue":"2","key":"10.1016\/j.cpet.2018.08.006_bib15","first-page":"287","article-title":"The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET\/CT","volume":"47","author":"Even-Sapir","year":"2006","journal-title":"J\u00a0Nucl Med"},{"issue":"8","key":"10.1016\/j.cpet.2018.08.006_bib16","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/RLU.0b013e31828da5cc","article-title":"Comparison of 18F fluoride PET\/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma","volume":"38","author":"Chakraborty","year":"2013","journal-title":"Clin Nucl Med"},{"issue":"3","key":"10.1016\/j.cpet.2018.08.006_bib17","first-page":"92","article-title":"The role of 18F-NaF PET\/CT in metastatic bone disease","volume":"4","author":"Araz","year":"2015","journal-title":"J\u00a0Bone Oncol"},{"issue":"3","key":"10.1016\/j.cpet.2018.08.006_bib18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/MNM.0b013e3283412ef5","article-title":"1)(8)F-fluoride PET\/CT for assessing bone involvement in prostate and breast cancers","volume":"32","author":"Withofs","year":"2011","journal-title":"Nucl Med Commun"},{"issue":"4","key":"10.1016\/j.cpet.2018.08.006_bib19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.rcl.2007.05.007","article-title":"Detection of bone metastases in breast cancer by positron emission tomography","volume":"45","author":"Schirrmeister","year":"2007","journal-title":"Radiol Clin North Am"},{"issue":"11","key":"10.1016\/j.cpet.2018.08.006_bib20","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2967\/jnumed.110.082263","article-title":"SNM practice guideline for sodium 18F-fluoride PET\/CT bone scans 1.0","volume":"51","author":"Segall","year":"2010","journal-title":"J\u00a0Nucl Med"},{"issue":"10","key":"10.1016\/j.cpet.2018.08.006_bib21","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1007\/s00259-008-0788-z","article-title":"Detection of bone metastases in patients with prostate cancer by F-18 fluorocholine and F-18 fluoride PET-CT: a comparative study","volume":"35","author":"Beheshti","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.cpet.2018.08.006_bib22","first-page":"162","article-title":"Differentiation of metastatic vs degenerative joint disease using semi-quantitative analysis with (18)F-NaF PET\/CT in castrate resistant prostate cancer patients","volume":"5","author":"Muzahir","year":"2015","journal-title":"Am J Nucl Med Mol Imaging"},{"issue":"11","key":"10.1016\/j.cpet.2018.08.006_bib23","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1007\/s00259-015-3080-z","article-title":"Appearance of untreated bone metastases from breast cancer on FDG PET\/CT: importance of histologic subtype","volume":"42","author":"Dashevsky","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"10.1016\/j.cpet.2018.08.006_bib24","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1258\/AR.2011.100507","article-title":"Comparison of FDG-PET\/CT and bone scintigraphy for detection of bone metastases in breast cancer","volume":"52","author":"Hahn","year":"2011","journal-title":"Acta Radiol"},{"issue":"19","key":"10.1016\/j.cpet.2018.08.006_bib25","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1200\/JCO.2009.27.5743","article-title":"Integrated positron emission tomography\/computed tomography may render bone scintigraphy unnecessary to investigate suspected metastatic breast cancer","volume":"28","author":"Morris","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.cpet.2018.08.006_bib26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/MNM.0000000000000481","article-title":"Clinical relevance of 18F-FDG-negative osteoblastic metastatic bone lesions noted on PET\/CT in breast cancer patients","volume":"37","author":"Al-Muqbel","year":"2016","journal-title":"Nucl Med Commun"},{"issue":"6","key":"10.1016\/j.cpet.2018.08.006_bib27","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1053\/j.semnuclmed.2016.07.004","article-title":"Is there use for FDG-PET in prostate cancer?","volume":"46","author":"Jadvar","year":"2016","journal-title":"Semin Nucl Med"},{"issue":"11","key":"10.1016\/j.cpet.2018.08.006_bib28","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/pros.22831","article-title":"Utility of FDG-PET in clinical neuroendocrine prostate cancer","volume":"74","author":"Spratt","year":"2014","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.cpet.2018.08.006_bib29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/iju.12250","article-title":"Update on positron emission tomography for imaging of prostate cancer","volume":"21","author":"Kitajima","year":"2014","journal-title":"Int J Urol"},{"issue":"2","key":"10.1016\/j.cpet.2018.08.006_bib30","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2214\/AJR.12.8816","article-title":"Molecular imaging of prostate cancer: PET radiotracers","volume":"199","author":"Jadvar","year":"2012","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.cpet.2018.08.006_bib31","doi-asserted-by":"crossref","first-page":"E37","DOI":"10.1002\/ijc.27779","article-title":"Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography\/computed tomography for the detection of metastases in non-small-cell lung cancer patients","volume":"132","author":"Wu","year":"2013","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.cpet.2018.08.006_bib32","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.clon.2010.10.002","article-title":"Fluorine-18 deoxyglucose positron emission tomography, magnetic resonance imaging and bone scintigraphy for the diagnosis of bone metastases in patients with lung cancer: which one is the best?--a meta-analysis","volume":"23","author":"Liu","year":"2011","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"8","key":"10.1016\/j.cpet.2018.08.006_bib33","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s12149-012-0622-3","article-title":"Comparison of diagnostic ability between (99m)Tc-MDP bone scan and (18)F-FDG PET\/CT for bone metastasis in patients with small cell lung cancer","volume":"26","author":"Lee","year":"2012","journal-title":"Ann Nucl Med"},{"issue":"5","key":"10.1016\/j.cpet.2018.08.006_bib34","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.ejrad.2011.01.126","article-title":"A\u00a0meta-analysis of (1)(8)FDG-PET-CT, (1)(8)FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer","volume":"81","author":"Qu","year":"2012","journal-title":"Eur J Radiol"},{"issue":"2","key":"10.1016\/j.cpet.2018.08.006_bib35","first-page":"379","article-title":"The skeletal metastatic complications of renal cell carcinoma","volume":"19","author":"Zekri","year":"2001","journal-title":"Int J Oncol"},{"issue":"9","key":"10.1016\/j.cpet.2018.08.006_bib36","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00432-002-0370-1","article-title":"Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphate bone scan to detect bone metastases in patients with renal cell carcinomas - a preliminary report","volume":"128","author":"Wu","year":"2002","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.cpet.2018.08.006_bib37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejrad.2009.11.019","article-title":"The potential clinical value of FDG-PET for recurrent renal cell carcinoma","volume":"79","author":"Nakatani","year":"2011","journal-title":"Eur J Radiol"},{"issue":"12","key":"10.1016\/j.cpet.2018.08.006_bib38","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1097\/MNM.0b013e328358d9c0","article-title":"Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT\/CT and 18F-FDG-PET\/CT for the detection of bone metastases from differentiated thyroid cancer","volume":"33","author":"Qiu","year":"2012","journal-title":"Nucl Med Commun"},{"issue":"8","key":"10.1016\/j.cpet.2018.08.006_bib39","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/MNM.0b013e32832dcfa7","article-title":"Value of 18F-FDG-PET\/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: a meta-analysis","volume":"30","author":"Dong","year":"2009","journal-title":"Nucl Med Commun"},{"issue":"11","key":"10.1016\/j.cpet.2018.08.006_bib40","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1089\/thy.2012.0302","article-title":"American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer","volume":"22","author":"Smallridge","year":"2012","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.cpet.2018.08.006_bib41","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cpet.2016.11.005","article-title":"Imaging of prostate cancer using fluciclovine","volume":"12","author":"Savir-Baruch","year":"2017","journal-title":"PET Clin"},{"issue":"7","key":"10.1016\/j.cpet.2018.08.006_bib42","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.7150\/thno.19883","article-title":"PET tracer 18F-fluciclovine can detect histologically proven bone metastatic lesions: a preclinical study in rat osteolytic and osteoblastic bone metastasis models","volume":"7","author":"Oka","year":"2017","journal-title":"Theranostics"},{"issue":"12","key":"10.1016\/j.cpet.2018.08.006_bib43","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.2967\/jnumed.114.143628","article-title":"Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease","volume":"55","author":"Schuster","year":"2014","journal-title":"J\u00a0Nucl Med"},{"issue":"8","key":"10.1016\/j.cpet.2018.08.006_bib44","doi-asserted-by":"crossref","first-page":"e386","DOI":"10.1097\/RLU.0000000000000849","article-title":"18F-Fluciclovine PET\/CT for the detection of prostate cancer relapse: a comparison to 11C-Choline PET\/CT","volume":"40","author":"Nanni","year":"2015","journal-title":"Clin Nucl Med"},{"issue":"5","key":"10.1016\/j.cpet.2018.08.006_bib45","first-page":"1446","article-title":"Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single\u00a0photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trial","volume":"191","author":"Schuster","year":"2014","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.cpet.2018.08.006_bib46","first-page":"87","article-title":"Phase IIa clinical trial of trans-1-amino-3-(18)F-fluoro-cyclobutane carboxylic acid in metastatic prostate cancer","volume":"2","author":"Inoue","year":"2014","journal-title":"Asia Ocean J Nucl Med Biol"},{"issue":"12","key":"10.1016\/j.cpet.2018.08.006_bib47","first-page":"11N","article-title":"FDA approves 11C-choline for PET in prostate cancer","volume":"53","year":"2012","journal-title":"J\u00a0Nucl Med"},{"issue":"8","key":"10.1016\/j.cpet.2018.08.006_bib48","doi-asserted-by":"crossref","first-page":"e893","DOI":"10.1016\/j.ejrad.2012.04.027","article-title":"Role of 11C-choline PET\/CT in the re-staging of prostate cancer patients with biochemical relapse and negative results at bone scintigraphy","volume":"81","author":"Fuccio","year":"2012","journal-title":"Eur J Radiol"},{"issue":"1","key":"10.1016\/j.cpet.2018.08.006_bib49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00259-011-1920-z","article-title":"[11C]Choline PET\/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy","volume":"39","author":"Picchio","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"10.1016\/j.cpet.2018.08.006_bib50","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s00256-014-1903-9","article-title":"Comparison of choline-PET\/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis","volume":"43","author":"Shen","year":"2014","journal-title":"Skeletal Radiol"},{"issue":"5","key":"10.1016\/j.cpet.2018.08.006_bib51","doi-asserted-by":"crossref","first-page":"e265","DOI":"10.1097\/RLU.0000000000000783","article-title":"11C-choline PET\/CT identifies osteoblastic and osteolytic lesions in patients with metastatic prostate cancer","volume":"40","author":"Ceci","year":"2015","journal-title":"Clin Nucl Med"},{"issue":"4","key":"10.1016\/j.cpet.2018.08.006_bib52","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/jcb.10662","article-title":"Prostate cancer bone metastases promote both osteolytic and osteoblastic activity","volume":"91","author":"Keller","year":"2004","journal-title":"J\u00a0Cell Biochem"},{"issue":"6","key":"10.1016\/j.cpet.2018.08.006_bib53","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.2214\/AJR.10.5491","article-title":"The utility of 11C-choline PET\/CT for imaging prostate cancer: a pictorial guide","volume":"196","author":"Murphy","year":"2011","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.cpet.2018.08.006_bib54","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.nucmedbio.2008.05.006","article-title":"[(11)C]Choline positron emission tomography\/computed tomography for staging and restaging of patients with advanced prostate cancer","volume":"35","author":"Tuncel","year":"2008","journal-title":"Nucl Med Biol"},{"issue":"7","key":"10.1016\/j.cpet.2018.08.006_bib55","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s12149-012-0610-7","article-title":"Benign fibrous dysplasia on [(11)C]choline PET: a potential mimicker of disease in patients with biochemical recurrence of prostate cancer","volume":"26","author":"Gu","year":"2012","journal-title":"Ann Nucl Med"},{"issue":"3","key":"10.1016\/j.cpet.2018.08.006_bib56","first-page":"105","article-title":"Imaging features of Paget's disease on 11C choline PET\/CT","volume":"7","author":"Leitch","year":"2017","journal-title":"Am J Nucl Med Mol Imaging"}],"container-title":["PET Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859818300956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859818300956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:05:52Z","timestamp":1761563152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556859818300956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1556859818300956"],"URL":"https:\/\/doi.org\/10.1016\/j.cpet.2018.08.006","relation":{},"ISSN":["1556-8598"],"issn-type":[{"type":"print","value":"1556-8598"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skeletal Metastasis Evaluation","name":"articletitle","label":"Article Title"},{"value":"PET Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpet.2018.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}